🇺🇸 Analgesic Therapy in United States

12 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

• Window: 22 April 2025 – 22 April 2026
• Total reports: 12

Most-reported reactions

1. Deafness Neurosensory — 2 reports (16.67%)
2. Tinnitus — 2 reports (16.67%)
3. Abasia — 1 report (8.33%)
4. Breast Cancer — 1 report (8.33%)
5. Breast Swelling — 1 report (8.33%)
6. Calciphylaxis — 1 report (8.33%)
7. Cough — 1 report (8.33%)
8. Diplegia — 1 report (8.33%)
9. Ear Infection — 1 report (8.33%)
10. Eustachian Tube Disorder — 1 report (8.33%)

Source database →

Frequently asked questions

Is Analgesic Therapy approved in United States?

Analgesic Therapy does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for Analgesic Therapy in United States?

University of Padova, School of Dental Medicine is the originator. The local marketing authorisation holder may differ — check the official source linked above.